Top line flat and the insurer loses market share in FY25; valuation attractive
Margins improvement will take time, but the product-mix story is playing out
The management expects value of new business to double in four years, despite the adverse impact of regulatory changes on margins.
HDFC Life posted flat annualised premium equivalent in FY24 as the changes introduced in the Budget 2023 impacted its high-ticket sized business
While the insurer’s low valuation helped the rally in the stock, the financial performance can add momentum, going forward
The valuation of the stock points to more upside, but certain issues are dogging the life insurance behemoth
The life insurer has a balanced product mix with focus on high-margin protection business
Healthy business growth with improving product mix, if sustained, can lead to a valuation re-rating of the life insurer gradually
Potential government interference, stiff competition, and lower VNB margins weigh on the life insurer’s stock
The life insurer’s stock is trading closer to its lowest level despite healthy operating performance
The re-rating of the stock is contingent upon the private life insurer’s ability to quickly grow its top line
LIC’s stock price jumped 6 percent on Monday, following the earnings announcement. Strong top-line growth compared to private players and not the ten-fold increase in profit was the reason for the rally
The business makeover should help this private life insurer accelerate business growth, along with higher margins
While the better product mix and higher VNB margin is encouraging, three things differentiate SBI Life from other private players – market leading share, largest bancassurance channel and lowest cost structure
ICICI Pru’s Q1 FY23 earnings underscore that it is well on track to achieve the VNB target for FY23
LIC's IPO is priced at a significant discount to private peers. Why so?
Business transformation visible in improving product mix, higher margins and enhanced distribution channels
LIC’s DRHP highlights many hits, but there are a few misses that should not be overlooked by investors
Given the promising sector outlook, which life insurance company’s stock is a worthy investment consideration at this juncture? Watch the video to find out the best bet among life insurers.
While COVID-19 is a speed breaker, it doesn’t derail the structural growth story of the life insurance sector
ICICI Pru is well on track to transit from a capital market player into a diversified franchise
The insurer‘s asset under management at the end of December 2016 (April to December) stood at Rs 113611 crore